
Do Oats Contain Gluten? Considerations for Introducing Oats in Patients with Celiac Disease
Certified gluten-free oats (<20 ppm gluten) can be included in a gluten-free diet for most patients with celiac disease. Understanding the benefits, patient selection criteria, and monitoring considerations can help support their safe introduction.
Oats and Celiac Disease: Recommendations for Safe Introduction
Patients with celiac disease understand that a gluten-free diet requires the elimination of wheat, barley, and rye, along with their derivatives. However, the role of oats in the gluten-free diet is often less straightforward.
For many years, oats were routinely excluded from the diet of individuals with celiac disease. Today, the scientific evidence supports the inclusion of certified gluten-free oats for most patients, provided appropriate safety and monitoring considerations are followed.
Understanding the benefits, limitations, and clinical considerations surrounding oat introduction can help healthcare professionals balance dietary variety and nutritional adequacy while maintaining a strict gluten-free diet.
Do oats contain gluten?
From a botanical perspective, oats are distinct from wheat, barley, and rye and do not contain gluten. Historical concerns about oat consumption in celiac disease stem primarily from two factors:
- Early studies that produced inconsistent or conflicting findings regarding oat safety
- Cross-contact with gluten-containing grains during growing, harvesting, processing, or manufacturing
Current evidence indicates that certified gluten-free oats can be safely consumed by most individuals with celiac disease, provided they are free from gluten contamination and introduced appropriately.
Why there is confusion and what the current consensus says
Historically, some studies raised concerns about oat consumption in individuals with with celiac disease. Subsequent research has shown that many of these findings were likely related to gluten contamination from wheat, barley, or rye during growing, transportation, storage, or processing rather than to oats themselves.
Current evidence indicates that certified gluten-free oats (<20 ppm gluten) are safe for most individuals with celiac disease and other gluten-related disorders when incorporated into a well-managed gluten-free diet.
As a result, the key clinical question is not whether oats naturally contain gluten, but whether they have been cross-contacted with gluten-containing grains and meet established gluten-free standards. Understanding the source and certification status of oat products is essential when providing guidance to patients with celiac disease.

How to identify safe, gluten-free oats?
The primary concern is not the oats themselves, but cross-contact with gluten-containing grains such as wheat, barley, or rye.
Contamination with wheat/barley and ryea
Oats are often grown, transported and processed in facilities where wheat, barley or rye are also handled. This is what can cause accidental contamination. Therefore, only certified gluten-free oats should be consumed, i.e. those that have been tested to ensure a gluten content of less than 20 parts per million (ppm).
What to look for on the label: "gluten-free" (<20 ppm) and symbols
To ensure that the oats are gluten-free, we must check:
- "Gluten-free" declaration on the packaging (<20 mg/kg).
- Recognised certification symbols, such as the crossed grain symbol. This applies to both oat flakes and oat flour. When it comes to oat flour, the benefits and contraindications will also depend on whether it is certified gluten-free.
Why are oats suitable for a gluten-free diet?
The adverse immune response associated with celiac disease is triggered by a group of storage proteins known as prolamins. These proteins are found in several cereal grains but have different names depending on the grain:
- Wheat → Gliadins
- Barley → Hordeins
- Rye → Secalins
- Oats → Avenins
How Is Avenin Different?
Avenin differs structurally and compositionally from the prolamins found in wheat, barley, and rye:
- Avenin accounts for a smaller proportion of total oat protein (approximately 10-20%) compared with gliadins in wheat (approximately 40-50%).
- Avenin contains lower levels of proline and glutamine (between 35 and 50% vs. >70% in wheat, barley, or rye), the amino acids most closely associated with the immunogenicity of gluten proteins.
- The molecular structure of avenin differs from the prolamins known to trigger celiac disease.
Current evidence indicates that most individuals with celiac disease can tolerate certified gluten-free oats. The avenin proteins found in oats generally do not provoke the same immune response as the gluten proteins in wheat, barley, and rye.
However, a small subset of patients may experience symptoms or show evidence of an immune response to oats. For this reason, oats should be introduced using certified gluten-free products and incorporated into ongoing clinical and dietary monitoring.
Oat tolerance varies among individuals
However, individual tolerance to oats can vary.
While most individuals with celiac disease tolerate certified gluten-free oats well, a small subset may experience symptoms or demonstrate sensitivity to specific oat varieties. Differences in the protein composition of avenin among oat cultivars may contribute to these responses. Currently, oat variety information is not routinely available on product labels.
As a result, although certified gluten-free oats are considered safe for most patients with celiac disease, tolerance should be assessed on an individual basis, with ongoing clinical and dietary monitoring as appropriate.
Benefits of including gluten-free oats
A gluten-free diet can be low in certain nutrients if not carefully planned and appropriately balanced.
Recommendations for successful introduction
Current clinical guidelines indicate that certified gluten-free oats can be included in the diet of individuals with celiac disease, provided they are monitored for tolerance and clinical response.
Continued oat consumption should be guided by the patient's symptoms, serologic markers, and, when appropriate, histologic findings.
Although certified gluten-free oats are safe for most patients with celiac disease, several practical considerations should be taken into account.
Fiber Introduction and GI Symptoms
Oats are a significant source of dietary fiber. A rapid increase in fiber intake may lead to gastrointestinal symptoms such as bloating, gas, abdominal discomfort, or changes in bowel habits. These symptoms may be transient but can sometimes be mistaken for ongoing gluten exposure or disease activity.
Individual Sensitivity and Oat Varieties
A small subset of patients may experience adverse symptoms despite consuming certified gluten-free oats. Differences in the protein composition of avenin among oat varieties (cultivars) have been proposed as a potential explanation, although the clinical significance of these differences remains an area of ongoing research.
At present, information about specific oat cultivars is generally not available on product labels, limiting the ability to identify potentially less well-tolerated varieties.
Key considerations for including oats in a gluten-free diet
Oats are naturally gluten-free; however, their safety in a gluten-free diet depends on the use of certified gluten-free products that meet established standards (<20 ppm gluten).
For most individuals with celiac disease or non-celiac gluten sensitivity, certified gluten-free oats can be included as part of the diet from the time of diagnosis and may provide important nutritional benefits, including increased fiber intake, improved dietary variety, and enhanced long-term adherence to the gluten-free diet.
Because individual tolerance can vary, the decision to continue oat consumption should be personalized and guided by ongoing assessment of symptoms, serologic markers, and, when clinically indicated, histologic findings. Certified gluten-free oats can be a valuable component of a healthy gluten-free diet when incorporated as part of individualized patient care.
You may also be interested in...

Celiac disease: Histological remission and follow-up care on a gluten-free diet
Read more: Celiac disease: Histological remission with a gluten-free diet
Case study: Persistent IBS symptoms with suspected histamine and gluten-related food intolerance
Read more: Case Study: Persistent IBS symptoms with suspected histamine and gluten-related food intolerance
Case study: Use of gluten-free staple foods to support adherence to a low FODMAP diet
Read more: Case study: Use of gluten-free staple foods to support adherence to a low FODMAP dietSources
- Beyond Celiac (n.d.) A small subset of those with celiac disease react to the protein in oat, study confirms. Available at: https://www.beyondceliac.org/research-news/a-small-subset-of-those-with-celiac-disease-react-to-the-protein-in-oat-study-confirms/ beyondceliac.org
- Chen, V., Zurbau, A., Ahmed, A., Khan, T., Kendall, C. and Sievenpiper, J. (2021) Effect of oats and oat-fiber on glycemic control in diabetes: A systematic review and meta-analysis of randomized controlled trials. Current Developments in Nutrition. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC8340782/ pmc.ncbi.nlm.nih.gov
- Coeliac UK (n.d.) Oats and the gluten-free diet. Available at: https://www.coeliac.org.uk/living-with-coeliac-disease/food-and-drink/food-and-drink-information/oats/ coeliac.org.uk
- Gilissen, L.J.W.J., Van der Meer, I.M. and Smulders, M.J.M. (2016) Why oats are safe and healthy for celiac disease patients. Medical Sciences, 4(4), 21. Available at: https://www.mdpi.com/2076-3271/4/4/21 mdpi.com
- Rodríguez, J.M., Estévez, V., Bascuñán, K. and Araya, M. (2022) Commercial oats in gluten-free diet: A persistent risk for celiac patients. Frontiers in Nutrition, 9:986282. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC9582257/ pmc.ncbi.nlm.nih.gov
- Spector Cohen, I., Day, A.S. and Shaoul, R. (2019) To be oats or not to be? An update on the ongoing debate on oats for patients with celiac disease. Frontiers in Pediatrics, 7:384. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC6775206/ pmc.ncbi.nlm.nih.gov
